logo
Plus   Neg
Share
Email

Conatus Pharmaceuticals Posting Strong Gain In Afternoon Trading

Shares of Conatus Pharmaceuticals (CNAT) have shown a strong move to the upside on Friday, with the biotechnology company climbing by 7.9 percent. Conatus reached a nearly two-month intraday high earlier in the session.

The jump by Conatus comes after the company announced that its exclusive license with Novartis (NVS) for the global development and commercialization of emricasan has become effective upon the receipt of a $7 million payment.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boeing may announce a decision on Monday whether to further cut or suspend production of the 737 Max aircraft amid growing uncertainty over the aircraft's return to service, the Wall Street Journal reported, citing people familiar with the matter. Shares of Boeing were losing almost 4 percent in Monday's pre-market activity. Shares of EVERTEC, Inc. (EVTC) saw a rise in trading volume to 536 million on Friday, vs. average trading volume of 366 million. The electronic payments company has gained prominence, because of its unique focus on Latin America, where rising cash-to-card conversion is fueling growth for the electronic... Fast food giant McDonald's fired an Australian franchisee, who owns two of its restaurants, over a video that showed him and a companion making racist comments against Aborigines. The company took control of the restaurants in Victoria from Robert Vigors, who made the racist rants at the home of neighbor Robby Wirramanda, an Indigenous artist.
Follow RTT
>